menu
    • menu

    Company profile for Sumitovant Biopharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our robust pipeline targets a range of disease areas with high unmet need. Our technology-enabled approach to drug discovery, development and commercialization gives our business tremendous scale. Guided by our leadership team with its strong track record of success, Sumitovant is well positioned to accelerate the delivery of medicines to patients who need new treatment options today. Our foremost purpose is to provide suppor...
    Our robust pipeline targets a range of disease areas with high unmet need. Our technology-enabled approach to drug discovery, development and commercialization gives our business tremendous scale. Guided by our leadership team with its strong track record of success, Sumitovant is well positioned to accelerate the delivery of medicines to patients who need new treatment options today. Our foremost purpose is to provide support, guidance and expertise to ensure the success of our subsidiaries. We aspire to be a growth engine for Sumitomo Dainippon Pharma, which means in addition to the products in our portfolio, we will source new assets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sumitovant BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    151 W. 42nd Street, 15th Floor New York, NY 10036
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sumitovant.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal

    10 Mar 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-10/sumitovant-biopharma-acquires-myovant-sciences-in-17b-deal/?widget=listSection

    CONTRACT PHARMA
    10 Mar 2023
    Share Share
    Neochromosome and Sumitovant Announce Collaboration for Protein Drug Discovery
    Neochromosome and Sumitovant Announce Collaboration for Protein Drug Discovery

    19 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230119005261/en

    BUSINESSWIRE
    19 Jan 2023
    Share Share
    Sumitovant subsidiaries Enzyvant and Altavant merge into combined company
    Sumitovant subsidiaries Enzyvant and Altavant merge into combined company

    06 Dec 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/sumitovant-subsidiaries-enzyvant-and-altavant-merge-into-combined-company/

    Tyler Patchen ENDPTS
    06 Dec 2022
    Share Share
    Weeks after Rejecting First Offer, Myovant Agrees to Acquisition by Sumitovant
    Weeks after Rejecting First Offer, Myovant Agrees to Acquisition by Sumitovant

    25 Oct 2022

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/weeks-after-rejecting-first-offer-myovant-agrees-to-acquisition-by-sumitovant/

    Alex Keown BIOSPACE
    25 Oct 2022
    Share Share
    Myovant's Board Confirms Sumitovant & Sumitomo to Acquire Remaining Shares
    Myovant's Board Confirms Sumitovant & Sumitomo to Acquire Remaining Shares

    02 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/02/2526430/0/en/Myovant-Sciences-Special-Committee-of-Board-Confirms-Receipt-of-Preliminary-Non-binding-Proposal-from-Sumitovant-Biopharma-and-Sumitomo-Pharma-to-Acquire-Remaining-Shares.html

    GLOBENEWSWIRE
    02 Oct 2022
    Share Share
    The Impact of Urinary Incontinence Related to Overactive Bladder
    The Impact of Urinary Incontinence Related to Overactive Bladder

    13 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220713005158/en

    BUSINESSWIRE
    13 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search